中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Progress in research of histone methyltransferases and their inhibitors in cancer treatment

文献类型:期刊论文

作者Zhang Jie; Ding Jian; Chen Yi
刊名Chinese Journal New Drugs
出版日期2014
卷号23期号:5页码:533-540
关键词histone methylation modification histone methyltransferases (HMTs) anti-cancer drug epigenetics
ISSN号1003-3734
其他题名组蛋白甲基转移酶及其相应抑制剂在抗肿瘤领域的研究进展
文献子类Review
英文摘要Aberrant histone methylation regulated by abnormal histone methyltransferases (HMTs) has emerged as a critical player in the onset and progression of cancer in numerous tumor types. The reversal of aberrant histone methylation changes has therefore emerged as a potential strategy for the treatment of cancer. A number of compounds targeting these HMTs have been developed as novel therapies, in which some are in clinical trials. This review highlights the roles of some HMTs in tumorigenesis and emerging therapies being developed for the treatment of cancer.
资助项目国家自然科学基金[00000000]
WOS研究方向Pharmacology & Pharmacy (provided by Clarivate Analytics)
语种中文
CSCD记录号CSCD:5101346
源URL[http://119.78.100.183/handle/2S10ELR8/269344]  
专题药理学第一研究室
作者单位Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
推荐引用方式
GB/T 7714
Zhang Jie,Ding Jian,Chen Yi. Progress in research of histone methyltransferases and their inhibitors in cancer treatment[J]. Chinese Journal New Drugs,2014,23(5):533-540.
APA Zhang Jie,Ding Jian,&Chen Yi.(2014).Progress in research of histone methyltransferases and their inhibitors in cancer treatment.Chinese Journal New Drugs,23(5),533-540.
MLA Zhang Jie,et al."Progress in research of histone methyltransferases and their inhibitors in cancer treatment".Chinese Journal New Drugs 23.5(2014):533-540.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。